시장보고서 | 연간정보서비스 | 맞춤형시장조사 | 메일링 | 샘플 요청 목록
세계의 인간 메타뉴모바이러스 진단 시장 보고서(2025년)
Human Metapneumovirus Diagnostics Global Market Report 2025
상품코드 : 1760555
리서치사 : The Business Research Company
발행일 : On Demand Report
페이지 정보 : 영문 175 Pages
 라이선스 & 가격 (부가세 별도)
US $ 4,490 ￦ 6,315,000
PDF (Single User License) help
PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 6,490 ￦ 9,128,000
PDF (Site License) help
PDF 보고서를 동일 사업장의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 8,490 ￦ 11,941,000
PDF (Enterprise License) help
PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.


ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.

한글목차

인간 메타뉴모바이러스 진단 시장 규모는 향후 몇 년 동안 10.1%의 연평균 성장률을 기록하며 2029년에는 7억 9,000만 달러 규모로 성장할 것으로 예상됩니다. 예측 기간 동안 예상되는 성장은 조기 및 정확한 호흡기 감염 진단에 대한 수요 증가, 현장 진단 솔루션에 대한 투자 확대, 신흥 시장에서의 의료 접근성 확대, 팬데믹 대응에 대한 전 세계적인 관심, 다중 호흡기 패널의 통합 확대 등이 배경이 될 것으로 예상됩니다. 배경입니다. 예측 기간의 주요 동향으로는 자동화 및 고처리량 진단 시스템 개발, 분산형 진단 모델로의 전환, 진단 해석에 인공지능 활용, 재택 검사 키트 채택 확대, 상장사와 비상장사의 협력 관계 확대 등을 꼽을 수 있습니다.

호흡기 감염증의 증가는 인간 메타뉴모바이러스 진단제 시장의 성장을 촉진할 것으로 예상됩니다. 바이러스, 박테리아 및 기타 병원체에 의한 호흡기 감염은 부비동, 인두, 기도 및 폐를 포함한 호흡기 계통에 영향을 미칩니다. 유병률의 증가는 유해한 오염물질에 대한 노출이 호흡기를 자극하고 약화시켜 감염에 취약하게 만드는 것과 관련이 있는 것으로 생각됩니다. 인간메타뉴모바이러스 진단약은 호흡기 감염증의 원인으로 hMPV를 식별하여 정확한 치료와 더 나은 관리를 가능하게 합니다. 예를 들어, 2025년 1월 영국 보건안전국은 2023-2024년 시즌 동안 영국의 호흡기 감염률이 2023년 50주와 52주에 10만 명당 8명으로 정점을 찍고, 2024년 4주에는 10만 명당 10.2명으로 더 높아질 것으로 예상했습니다.에서의 급성 호흡기 감염 발생 건수는 2,051건에 이르렀으며, 대부분의 사례가 요양시설과 병원에서 보고되었다고 보고했습니다. 이러한 호흡기 감염증의 확산은 인간메타뉴모바이러스 진단제 시장 확대에 박차를 가하고 있습니다.

인간 메타뉴모바이러스 진단제 시장의 주요 기업들은 호흡기 중합효소 연쇄 반응(PCR) 진단 도구와 같은 혁신적인 솔루션 개발에 집중하며 다양한 호흡기 병원체를 검출하는 분자진단 역량을 강화하고 있습니다. 호흡기 PCR 진단 솔루션은 호흡기 병원체의 유전물질을 고감도, 고특이성으로 증폭하여 검출 및 동정하는 분자 검사법입니다. 예를 들어, 2023년 3월 중국 소재 분자진단 회사인 Jiangsu BioPerfectus Technologies Co, Ltd.는 호흡기 병원체 다중 실시간 PCR 진단 키트를 출시하였습니다. 이 솔루션은 여러 호흡기 병원체를 동시에 높은 정확도로 신속하게 검출할 수 있도록 설계되어 임상 현장과 진료 현장에서 진단 효율을 향상시킵니다. 광범위한 적용 범위와 정확한 성능은 특히 증상이 중복되는 호흡기 감염증의 관리에서 적시에 임상적 의사결정을 내리는 데 큰 도움이 될 것입니다.

목차

제1장 주요 요약

제2장 시장 특징

제3장 시장 동향과 전략

제4장 시장 - 금리, 인플레이션, 지정학, 무역 전쟁과 관세, 그리고 코로나와 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오

제5장 세계의 성장 분석과 전략 분석 프레임워크

제6장 시장 세분화

제7장 지역별·국가별 분석

제8장 아시아태평양 시장

제9장 중국 시장

제10장 인도 시장

제11장 일본 시장

제12장 호주 시장

제13장 인도네시아 시장

제14장 한국 시장

제15장 서유럽 시장

제16장 영국 시장

제17장 독일 시장

제18장 프랑스 시장

제19장 이탈리아 시장

제20장 스페인 시장

제21장 동유럽 시장

제22장 러시아 시장

제23장 북미 시장

제24장 미국 시장

제25장 캐나다 시장

제26장 남미 시장

제27장 브라질 시장

제28장 중동 시장

제29장 아프리카 시장

제30장 경쟁 구도와 기업 개요

제31장 기타 주요 기업과 혁신적 기업

제32장 세계의 시장 경쟁 벤치마킹과 대시보드

제33장 주요 인수합병

제34장 최근의 시장 동향

제35장 시장 잠재력이 높은 국가, 부문, 전략

제36장 부록

ksm
영문 목차

영문목차

Human metapneumovirus (hMPV) diagnostics involve the methods and criteria used to detect and confirm infection with human metapneumovirus, a respiratory pathogen that can cause illnesses ranging from mild cold-like symptoms to severe respiratory infections, particularly in children, the elderly, and immunocompromised individuals.

The primary product types in human metapneumovirus diagnostics are reagents and kits, as well as instruments. Reagents and kits are essential laboratory products that contain chemical substances and tools for performing specific diagnostic tests or experiments. The diagnostic test types include molecular diagnostics, immunodiagnostics, culture-based methods, and others, utilizing technologies such as PCR-based diagnostics, next-generation sequencing (NGS), immunofluorescence assays, lateral flow assays, microarray technology, and others. These tests are used in various settings, including hospitals and clinics, diagnostic and reference laboratories, academic and research institutions, among others.

The human metapneumovirus diagnostics market research report is one of a series of new reports from The Business Research Company that provides human metapneumovirus diagnostics market statistics, including human metapneumovirus diagnostics industry global market size, regional shares, competitors with a human metapneumovirus diagnostics market share, detailed human metapneumovirus diagnostics market segments, market trends and opportunities, and any further data you may need to thrive in the human metapneumovirus diagnostics industry. This human metapneumovirus diagnostics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The human metapneumovirus diagnostics market size has grown rapidly in recent years. It will grow from $0.49 billion in 2024 to $0.54 billion in 2025 at a compound annual growth rate (CAGR) of 10.3%. The growth observed in the historical period can be attributed to an increase in pediatric hospitalization rates due to respiratory infections, heightened awareness of viral respiratory pathogens, the initial adoption of molecular diagnostic tools, the expansion of public health surveillance programs, and greater funding for pediatric respiratory diseases.

The human metapneumovirus diagnostics market size is expected to see rapid growth in the next few years. It will grow to $0.79 billion in 2029 at a compound annual growth rate (CAGR) of 10.1%. The growth anticipated in the forecast period is driven by rising demand for early and accurate respiratory infection diagnostics, growing investments in point-of-care diagnostic solutions, expanding healthcare access in emerging markets, a global focus on pandemic preparedness, and greater integration of multiplex respiratory panels. Key trends in the forecast period include the development of automated and high-throughput diagnostic systems, a shift toward decentralized diagnostic models, the use of artificial intelligence in diagnostic interpretation, the increasing adoption of at-home testing kits, and growing collaboration between public and private diagnostic companies.

The increasing prevalence of respiratory infections is expected to drive growth in the human metapneumovirus diagnostics market. Respiratory infections, caused by viruses, bacteria, or other pathogens, affect the respiratory system, including the sinuses, throat, airways, and lungs. The rising prevalence can be linked to the exposure to harmful pollutants that irritate and weaken the respiratory tract, making it more susceptible to infections. Human metapneumovirus diagnostics help identify hMPV as the cause of respiratory infections, allowing for accurate treatment and better management. For example, in January 2025, the UK Health Security Agency reported that during the 2023-2024 season, respiratory infection rates in England peaked at 8.0 per 100,000 in weeks 50 and 52 of 2023, and rose further to 10.2 per 100,000 in week 4 of 2024, while acute respiratory infection incidents in closed settings reached 2,051, with most cases reported in care homes and hospitals. This growing prevalence of respiratory infections is fueling the expansion of the human metapneumovirus diagnostics market.

Leading companies in the human metapneumovirus diagnostics market are focusing on developing innovative solutions, such as respiratory polymerase chain reaction (PCR) diagnostic tools, to enhance molecular diagnostic capabilities for detecting a wide range of respiratory pathogens. A respiratory PCR diagnostic solution is a molecular testing method used to detect and identify respiratory pathogens by amplifying their genetic material with high sensitivity and specificity. For example, in March 2023, Jiangsu BioPerfectus Technologies Co., Ltd., a molecular diagnostic company based in China, launched its respiratory pathogen multiplex real-time PCR diagnostic kit. This solution is designed to simultaneously detect multiple respiratory pathogens with high accuracy and a rapid turnaround time, improving diagnostic efficiency in clinical and point-of-care settings. Its broad coverage and precise performance significantly aid timely clinical decision-making, particularly for managing respiratory infections with overlapping symptoms.

In February 2024, AstraZeneca plc, a pharmaceutical company based in the UK, acquired Icosavax Inc. for an undisclosed amount. With this acquisition, AstraZeneca aims to enhance its late-stage pipeline and expand its expertise in vaccines for respiratory conditions with high burdens, specifically advancing Icosavax's lead investigational combination vaccine candidate, IVX-A12, which targets both respiratory syncytial virus (RSV) and human metapneumovirus (hMPV). Icosavax Inc., a biotechnology company based in the US, focuses on developing vaccines, especially combination vaccines targeting respiratory viruses such as RSV and hMPV.

Major players in the human metapneumovirus diagnostics market are F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Abbott Laboratories, Quest Diagnostics, Hologic Inc., QuidelOrtho Corporation, Bio-Rad Laboratories Inc., ARUP Laboratories, Qiagen NV, Diasorin, Luminex Corporation, bioMerieux, Seegene Inc., Cepheid, R-Biopharm AG, Certest Biotec, ZeptoMetrix, Xi'an Tianlong Science and Technology Co. Ltd, The Native Antigen Company, Hangzhou Testsea Biotechnology Co. Ltd., and Attogene.

North America was the largest region in the human metapneumovirus diagnostics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in human metapneumovirus diagnostics report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the human metapneumovirus diagnostics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The human metapneumovirus diagnostics market consists of revenues earned by entities by providing services such as diagnostic testing services, clinical laboratory services, point-of-care testing services, home sample collection services, public health surveillance services, and contract research and testing services. The market value includes the value of related goods sold by the service provider or included within the service offering. The human metapneumovirus diagnostics market also includes sales of sample collection devices, diagnostic data management tools, test validation kits, and safety and waste disposal systems. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Human Metapneumovirus Diagnostics Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on human metapneumovirus diagnostics market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Where is the largest and fastest growing market for human metapneumovirus diagnostics ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The human metapneumovirus diagnostics market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

Scope

Table of Contents

1. Executive Summary

2. Human Metapneumovirus Diagnostics Market Characteristics

3. Human Metapneumovirus Diagnostics Market Trends And Strategies

4. Human Metapneumovirus Diagnostics Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Human Metapneumovirus Diagnostics Growth Analysis And Strategic Analysis Framework

6. Human Metapneumovirus Diagnostics Market Segmentation

7. Human Metapneumovirus Diagnostics Market Regional And Country Analysis

8. Asia-Pacific Human Metapneumovirus Diagnostics Market

9. China Human Metapneumovirus Diagnostics Market

10. India Human Metapneumovirus Diagnostics Market

11. Japan Human Metapneumovirus Diagnostics Market

12. Australia Human Metapneumovirus Diagnostics Market

13. Indonesia Human Metapneumovirus Diagnostics Market

14. South Korea Human Metapneumovirus Diagnostics Market

15. Western Europe Human Metapneumovirus Diagnostics Market

16. UK Human Metapneumovirus Diagnostics Market

17. Germany Human Metapneumovirus Diagnostics Market

18. France Human Metapneumovirus Diagnostics Market

19. Italy Human Metapneumovirus Diagnostics Market

20. Spain Human Metapneumovirus Diagnostics Market

21. Eastern Europe Human Metapneumovirus Diagnostics Market

22. Russia Human Metapneumovirus Diagnostics Market

23. North America Human Metapneumovirus Diagnostics Market

24. USA Human Metapneumovirus Diagnostics Market

25. Canada Human Metapneumovirus Diagnostics Market

26. South America Human Metapneumovirus Diagnostics Market

27. Brazil Human Metapneumovirus Diagnostics Market

28. Middle East Human Metapneumovirus Diagnostics Market

29. Africa Human Metapneumovirus Diagnostics Market

30. Human Metapneumovirus Diagnostics Market Competitive Landscape And Company Profiles

31. Human Metapneumovirus Diagnostics Market Other Major And Innovative Companies

32. Global Human Metapneumovirus Diagnostics Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Human Metapneumovirus Diagnostics Market

34. Recent Developments In The Human Metapneumovirus Diagnostics Market

35. Human Metapneumovirus Diagnostics Market High Potential Countries, Segments and Strategies

36. Appendix

(주)글로벌인포메이션 02-2025-2992 kr-info@giikorea.co.kr
ⓒ Copyright Global Information, Inc. All rights reserved.
PC버전 보기